Pathology News
editor

About Editor

This author has not yet filled in any details.
So far Editor has created 845 blog entries.

April 2026

From Glass to Intelligence at Scale: How Rede D’Or Built Latin America Most Ambitious Digital Pathology Transformation

2026-05-05T15:36:49+00:00

A 3-year roadmap completed in just 9 months. Zero pathologists wanted to go back to glass. That’s what Rede D'Or, Latin America’s largest hospital network, achieved with PathAI’s AISight® IMS platform. What began as an ambitious digital pathology initiative became a network-wide transformation across São Paulo, Rio de Janeiro, and Bahia in less than a year. [...]

From Glass to Intelligence at Scale: How Rede D’Or Built Latin America Most Ambitious Digital Pathology Transformation2026-05-05T15:36:49+00:00

AI Powered QC Where You Need It: Finding Needles in the Haystack

2026-08-26T11:52:33+00:00

Through live demonstrations, and interactive discussions, attendees will understand the prevalence of artifacts and challenges of manual quality control (QC) for whole slide imaging (WSI). Learn how AI-powered QC helps labs identify the minority of slides with artifacts, freeing up technician time to focus on the critical few. Innovative, cutting-edge rescan functionality is designed to fix [...]

AI Powered QC Where You Need It: Finding Needles in the Haystack2026-08-26T11:52:33+00:00

AI-Powered Immune Score Reveals New Treatment Pathways for Rare Adrenal Cancer

2026-04-27T09:45:34+00:00

by Christos Evangelou, MSc, PhD – Medical Writer and Editor  Adrenocortical carcinoma (ACC), a rare endocrine malignancy affecting fewer than two people per million annually, has a poor prognosis. Mitotane is currently the only FDA-approved first-line therapy, and there is limited understanding of which patients might respond to emerging immunotherapies. In a recent study, researchers developed an AI-driven scoring system that integrates tumor metabolism, immune infiltration, and digital pathology [...]

AI-Powered Immune Score Reveals New Treatment Pathways for Rare Adrenal Cancer2026-04-27T09:45:34+00:00

Fimlab Expands Utilization of Aiforia’s Clinical AI Solutions

2026-05-05T10:48:22+00:00

Aiforia Technologies Plc announced today that Fimlab Laboratories in Finland has expanded the use of Aiforia’s AI solutions in routine clinical workflow. Already in 2025, as part of the first deployment batch under the framework agreement, Fimlab implemented Aiforia’s breast cancer diagnostics solution – a complete suite for both breast cancer grading and biomarker panels. Now, [...]

Fimlab Expands Utilization of Aiforia’s Clinical AI Solutions2026-05-05T10:48:22+00:00

Lessons learned from three approaches to digital pathology system validation at a large academic medical institution

2026-04-29T12:07:46+00:00

The following abstract is drawn from a recently published paper in Journal of Pathology Informatics. We invite you to read the full paper and join the conversation, become a member of the Pathology News community to share your thoughts, ask questions, and engage with others around this work. Authors: Tara Krishnan, Jamie Garrett, Jonathan Henriksen, [...]

Lessons learned from three approaches to digital pathology system validation at a large academic medical institution2026-04-29T12:07:46+00:00

Digital Diagnostic Summit Launches Specialty-Specific Educational Series to Accelerate Innovation in Prostate Cancer Diagnostics

2026-05-05T10:24:33+00:00

Inaugural DDx Summit Educational Series to Focus on Urology and Prostate Cancer, Uniting Innovators for an Immersive 24-Hour Program The Digital Diagnostic Summit (DDx Summit), established in 2022 to move beyond theory and into real-world implementation of digital pathology, workflow innovation, and integrated diagnostics, has become a platform where proven innovation turns into a roadmap [...]

Digital Diagnostic Summit Launches Specialty-Specific Educational Series to Accelerate Innovation in Prostate Cancer Diagnostics2026-05-05T10:24:33+00:00

Aiforia Has Been Selected as an AI Partner for the PROSTIA Project – Expands to Five New Hospitals in Paris

2026-04-28T11:29:05+00:00

Aiforia France, a subsidiary of Aiforia Technologies Plc, has been selected as the AI partner for the PROSTIA project led by Assistance Publique–Hôpitaux de Paris (AP-HP). This initiative will deploy Aiforia’s CE-IVD-marked prostate cancer diagnostic solution across all AP-HP pathology sites involved in the management of prostatic pathologies, expanding an ongoing collaboration initiated in 2024 at [...]

Aiforia Has Been Selected as an AI Partner for the PROSTIA Project – Expands to Five New Hospitals in Paris2026-04-28T11:29:05+00:00

PathAI’s AISight IMS Platform: An Open Digital Pathology Platform Enabling Flexible Choice Across AI Applications

2026-04-28T11:02:24+00:00

As digital pathology adoption grows, labs are no longer just evaluating scanners, image management systems, or LIS connectivity. Increasingly, they are asking a more strategic question, reflecting the vision that AI will unlock major efficiencies and growth opportunities in lab operations: what AI applications can this platform support, and how can I future proof my workflow [...]

PathAI’s AISight IMS Platform: An Open Digital Pathology Platform Enabling Flexible Choice Across AI Applications2026-04-28T11:02:24+00:00

Micro Highlight #34 – A First Look at the 2026 KLAS Report on Digital Pathology: Lessons from Early Adopters

2026-04-29T09:54:38+00:00

On March 27, 2026, the Panel of National Pathology Leaders convened its first Digital Pathology & AI Focus Group meeting of the year, featuring a presentation by Eder Lagemann, Vice President of Engagement at KLAS Research. Lagemann, a co-author of the newly released Digital Pathology 2026: Early Adoption and Technology Performance in an Emerging U.S. Market report, shared insights derived from [...]

Micro Highlight #34 – A First Look at the 2026 KLAS Report on Digital Pathology: Lessons from Early Adopters2026-04-29T09:54:38+00:00

Aiforia Closes a Seal with a Private Diagnostic Laboratory in Italy

2026-04-27T09:09:48+00:00

Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. Using Aiforia’s distinct AI development platform, Aiforia® Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. The developed AI models will be implemented in [...]

Aiforia Closes a Seal with a Private Diagnostic Laboratory in Italy2026-04-27T09:09:48+00:00
Go to Top